Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison
about
New drugs in hypertensionExertional hypotension due to postganglionic sympathetic blocking drugsSide effects of hypotensive agents evaluated by a self-administered questionnaireA within-patient comparison of debrisoquine and methyldopa in hypertensionTreatment of hypertension with propranololEvaluation of the effects of drugs on sexual behavior.The management of hypertensionLabetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.A comparison of the effects of labetalol, bendrofluazide and their combination in hypertensionClinical observations on the use of debrisoquine sulphate (Declinas) in the treatment of hypertension.Three cases of severe hypertension controlled with propranololThe second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.The effects of atenolol (tenormin) and methyldopa on simple tests of central nervous functionDrug-induced sexual dysfunction.Comparison of labetalol with other anti-hypertensive drugs.Pharmacosexology: the effects of drugs on sexual function a review.The discovery of bretylium and bethanidine.Problems with Beta Adrenergic Blocking Drugs and other Antihypertensive Drugs.Treatment of hypertension with propranol.
P2860
Q24680276-8913BB8E-17A9-4B08-BDCE-558B1993F55AQ28334730-B380455B-4863-4FAF-9C9C-8BCBCDBC6D67Q28363952-5CD40C91-D0CE-4D67-A14A-0CAE696BD1CBQ28365310-F24AF885-9FED-4E65-B50A-23A1BAD022EAQ28365473-2AC35E53-3DF2-402F-921B-E4B09D426B91Q34220003-E43DF104-836C-40AC-AD11-80073F46A61EQ34446787-604ADE61-A2A0-4338-BD6D-F66D28F0E1D3Q34517987-D895ADEB-1944-4779-A9D5-D559B29BBBF0Q34518025-DAD9D7CB-C523-484B-8FBD-ED38B5D96E7BQ34703621-89C0CAB0-9347-4AF5-AF56-213679D30F3DQ35861460-519D5C56-21DC-47D1-B1CC-E6ECE1053C0EQ38586764-3F595041-76C2-488D-960F-936AC0029E91Q39116180-FB67FCC5-E0EC-454B-8B63-C327FA35C0D2Q39536351-33833E38-6A7C-48E9-BC26-1E35AE87AFECQ40087201-F5808E0C-CE26-499D-BFE1-710987763677Q40087979-E04724B4-1421-40BB-B8E1-308DF1F9DF96Q41815856-B9EFFD4A-8903-48E7-9893-4FB71A7B307AQ42701305-6D196D63-879D-4A22-9AC6-25639721C16BQ49175648-10388407-F2E2-4D0A-A687-E078620A0EE8
P2860
Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison
description
1968 nî lūn-bûn
@nan
1968 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1968 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1968年の論文
@ja
1968年論文
@yue
1968年論文
@zh-hant
1968年論文
@zh-hk
1968年論文
@zh-mo
1968年論文
@zh-tw
1968年论文
@wuu
name
Bethanidine, Guanethidine, and ...... n: a Within-patient Comparison
@ast
Bethanidine, Guanethidine, and ...... n: a Within-patient Comparison
@en
Bethanidine, Guanethidine, and ...... n: a Within-patient Comparison
@nl
type
label
Bethanidine, Guanethidine, and ...... n: a Within-patient Comparison
@ast
Bethanidine, Guanethidine, and ...... n: a Within-patient Comparison
@en
Bethanidine, Guanethidine, and ...... n: a Within-patient Comparison
@nl
prefLabel
Bethanidine, Guanethidine, and ...... n: a Within-patient Comparison
@ast
Bethanidine, Guanethidine, and ...... n: a Within-patient Comparison
@en
Bethanidine, Guanethidine, and ...... n: a Within-patient Comparison
@nl
P2093
P356
P1433
P1476
Bethanidine, Guanethidine, and ...... n: a Within-patient Comparison
@en
P2093
A W Johnston
B N Prichard
M L Rosenheim
P2860
P304
P356
10.1136/BMJ.1.5585.135
P407
P577
1968-01-20T00:00:00Z